2007
DOI: 10.1201/9781420054408
|View full text |Cite
|
Sign up to set email alerts
|

Six Sigma in the Pharmaceutical Industry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 6 publications
0
6
0
Order By: Relevance
“…It is a probability that the modification of the fermentation unit of the bioprocess or improvement of operations in downstream processing may result in the design and optimization advancement of the pharmaceutical production process [ 48 ]. It is found that quality control strategies (including Six Sigma) as a means to either improve production or to enhance product quality in the pharmaceutical industries have been proposed or predicted through simulations by diverse groups [ 49 53 ]. An early study forecasted a theoretical model for penicillin synthesis, with qualitative prediction of different developments that are generally countered in experiments and also reviewed various models for secondary metabolite manufacturing [ 49 ].…”
Section: Six Sigma Methodology: An Overviewmentioning
confidence: 99%
See 2 more Smart Citations
“…It is a probability that the modification of the fermentation unit of the bioprocess or improvement of operations in downstream processing may result in the design and optimization advancement of the pharmaceutical production process [ 48 ]. It is found that quality control strategies (including Six Sigma) as a means to either improve production or to enhance product quality in the pharmaceutical industries have been proposed or predicted through simulations by diverse groups [ 49 53 ]. An early study forecasted a theoretical model for penicillin synthesis, with qualitative prediction of different developments that are generally countered in experiments and also reviewed various models for secondary metabolite manufacturing [ 49 ].…”
Section: Six Sigma Methodology: An Overviewmentioning
confidence: 99%
“…Case studies that involve integration of Six Sigma methodology in pharmaceutical production unit have been conducted in related areas such as biological, parenteral operations, safety, and improved control of potency [ 53 ]. Six Sigma can serve as the driving force for continuous improvement by identifying the root cause or causes of low process yield, due to excessive variance in the desired specifications [ 52 ].…”
Section: Six Sigma Methodology: An Overviewmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, the larger the process variation, the more likely it is for a process to fail to meet manufacturing specifications. In fact, reduced process variation can even lower cycle time in manufacturing . As such, the ability to quantify and model variation is a key element in QbD.…”
Section: Role Of Batch-to-batch Variation In Qbdmentioning
confidence: 99%
“…In an attempt to explore a most probably strong causal relationship between the symptoms and their reasoning, it is becoming quite obvious that the major root cause might be found lying deep within the management culture of the pharmaceutical industry, the values of which reflect much more the world of business rather than the rational world of statistical thinking and knowledge management (11,16).…”
mentioning
confidence: 99%